PTGS2 and colorectal carcinoma: Małgorzata Kapral et al. found that IP6 prevents CRC by limiting inflammatory events in the colon epithelium by regulating the expression of COX-2 and 5-LOX proteins, as well as by affecting the synthesis and secretion of PGE2 and LTB4162.